{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:10:07Z","timestamp":1783105807514,"version":"3.54.6"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,20]]},"DOI":"10.1097\/cm9.0000000000003102","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T02:00:06Z","timestamp":1716170406000},"page":"1973-1975","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["An E2F7\/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria"],"prefix":"10.1097","volume":"137","author":[{"given":"Lincheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, Zhejiang 310022, China"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China"},{"name":"National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunbin","family":"Ling","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, Hangzhou First People\u2019s Hospital, Hangzhou, Zhejiang 310006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China"},{"name":"National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, Zhejiang 310003, China"},{"name":"School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"R1-20250602","first-page":"2911","article-title":"Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)","volume":"135","author":"Chen","year":"2022","journal-title":"Chin Med J"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ejso.2021.04.001","article-title":"Sirolimus-based immunosuppression improves the prognosis of liver transplantation recipients with low TSC1\/2 expression in hepatocellular carcinoma beyond the Milan criteria","volume":"47","author":"Ye","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/ajt.17124","article-title":"E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation","volume":"22","author":"Ling","year":"2022","journal-title":"Am J Transplant"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","article-title":"USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1\u03b1\/USP22 positive feedback loop upon TP53 inactivation","volume":"69","author":"Ling","year":"2020","journal-title":"Gut"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd.2017.226","article-title":"Drug development in the era of precision medicine","volume":"17","author":"Dugger","year":"2018","journal-title":"Nat Rev Drug Discov"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:01:35Z","timestamp":1748890895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":5,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003102","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]},"assertion":[{"value":"2023-05-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}